Abstract: The invention provides a method for treating lung cancer or breast cancer wherein the method comprises administering a pharmaceutically effective dose of arazyme enzyme to a subject with lung cancer or breast cancer. The arazyme enzyme is either a protein comprising the amino acid sequence of SEQ ID NO: 1; and/or a protein encoded by DNA comprising the coding region of the nucleotide sequence of SEQ ID NO: 2.
Type:
Grant
Filed:
September 2, 2011
Date of Patent:
March 19, 2013
Assignee:
Inssect Biotech Co., Ltd.
Inventors:
Ho-Yong Park, Kwang-Hee Son, Dong-Ha Shin, Kyu-Shik Jeong